← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 DELISTED CARGO Therapeutics CRGX	–	–	–	–
77	DBTX 77 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
78	78 Precision BioSciences DTIL $166M	–	–	–	–
79	79 enGene Therapeutics ENGN $105M	–	–	–	–
80	80 Estrella Immunopharma ESLA $13.8M	–	–	–	–
81	81 FibroBiologics FBLG $6.73M	–	–	–	–
82	82 4D Molecular Therapeutics FDMT $674M	–	–	–	–
83	FRLN 83 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
84	84 DELISTED Generation Bio GBIO	–	–	–	–
85	85 CytoMed Therapeutics GDTC $10.3M	–	–	–	–
86	GMDA 86 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
87	87 Genenta Science GNTA $31.8M	–	–	–	–
88	GRCL 88 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
89	GRML 89 Greenland Mines Ltd GRML $86.6M	–	–	–	–
90	90 Fractyl Health GUTS $54.1M	–	–	–	–
91	91 Immix Biopharma IMMX $706M	–	–	–	–
92	92 Immatics IMTX $1.07B	–	–	–	–
93	93 IN8bio INAB $11.8M	–	–	–	–
94	94 MiNK Therapeutics INKT $52.8M	–	–	–	–
95	95 INmune Bio INMB $44.4M	–	–	–	–
96	96 Century Therapeutics IPSC $250M	–	–	–	–
97	KRBP 97 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
98	98 Kyverna Therapeutics KYTX $351M	–	–	–	–
99	99 Legend Biotech LEGN $3.7B	–	–	–	–
100	LGVN 100 Longeveron LGVN $5.52M	–	–	–	–